Foligraf 75iu

Introduction

Foligraf 75 IU is a drug that is mostly utilized in fertility treatments. It is a supplement to Follitropin alfa, which is a recombinant version of human Follicle Stimulating Hormone (FSH). FSH is a natural hormone that is produced by the pituitary gland. The hormone has a major role to play in the development and growth of ovarian follicles for women and the production of sperm by males.

Foligraf is typically used to aid women who undergo assisted reproductive technology (ART), including IVF (IVF) or intrauterine insemination (IUI), by stimulating the ovaries to make numerous eggs. Foligraf is also used for men suffering from certain forms of infertility.

Composition

• Active ingredient: Follitropin alfa (recombinant FSH)
• Strength: 75 International Units (IU) per vial or prefilled injection device
• Form: Injectable solution, typically administered subcutaneously or intramuscularly

Mechanism of Action

Foligraf includes the recombinant FSH that mimics naturally occurring FSH hormone. FSH attaches to the receptors of female ovarian follicles. It stimulates the growth and maturation of the follicles. This leads to ovulation.

• For women, it aids in the development of follicular hairs and increases the production of estrogen.
• In males, it promotes the process of spermatogenesis through Sertoli cells that are found in the testes.

Through the administration of controlled doses of FSH, Foligraf enables the growth of multiple follicles, improving the odds of success in ovulation and pregnancy when using treatment for fertility.

Indications

Foligraf 75 IU is used for:

• Hyperstimulation of the ovary is controlled in women who are undergoing assisted reproduction (IVF, ICSI, IUI)
• Treatment for an anovulation or oligoovulation caused by pituitary dysfunction or any other cause
• Hypogonadotropic hypogonadism for men, to increase the spermatogenesis (often in combination with high-grade hCG)
• Female infertility is a result of the endogenous FSH insufficiency

Dosage and Administration

• Initial dose: In general, 75 IU daily is delivered via subcutaneous or intramuscular injection.
• The dosage can be adjusted depending on the response of the ovaries, which is measured via ultrasound as well as estradiol levels.
• Duration: Usually, it is given over 7 to 12 days, or until sufficient growth of the follicular hair is seen.
• The treatment should be overseen by a fertility doctor to avoid risks such as ovarian hyperstimulation disorder (OHSS).

Important: The specific dosing procedure depends upon the specific patient’s factors, including age, ovarian reserve of ovaries as well as previous responses, as well as the particular fertility program.

Monitoring During Treatment

• Regular ultrasonography scans are used to determine the size and the number.
• Tests of blood to check the level of estradiol.
• Modifications in dosage or stopping could be required to avoid issues such as the OHSS.

Side Effects

The majority of patients tolerate Foligraf quite well. However, adverse consequences could be:

Common Side Effects:

• Injection site reactions (pain, redness, swelling)
• Headache
• Fatigue
• Abdominal discomfort or bloating

Serious Side Effects:

• Ovarian Hyperstimulation Syndrome (OHSS) — an illness that can be very serious can be fatal. It is characterized by symptoms such as an increase in weight quickly, stomach pain, nausea, vomiting, and the feeling of having a short breath.
• Multiple pregnancies (twins or more), increasing pregnancy risks.
• Allergic reactions (rare)

Precautions

• Foligraf shouldn’t be used for women who suffer from:
  • Ovarian cysts unrelated to polycystic ovary syndrome (PCOS)
  • Unexplained vaginal bleeding
  • Hormone-sensitive cancers (breast, ovarian, uterine)
  • Pregnancy or lactation
• Monitoring is vital in order to reduce the chance of OHSS.
• Do not have multiple ovulations unless wanted.

Contraindications

• Hypersensitivity to follitropinalfa or any other ingredient in the formulation.
• Tumors of the hypothalamus or pituitary gland.
• Primary ovarian failure.
• Sex hormone-dependent tumors.
• Pregnancy or lactation.

Storage

• Storage Foligraf 75 IU kept refrigerated until 2- 8°C.
• Be safe from the sunlight.
• Don’t freeze.
• Utilize the medicine for the time period that is recommended following the closing.

Summary

Foligraf 75 IU is a key medication in fertility treatment that aids in stimulating follicular growth through the provision of recombinant FSH. It is a drug that requires expert monitoring due to the potential of a variety of negative side effects, including OHSS. Monitoring and individualized dosage increase the chances of success in assisted reproductive technology.